▶ 調査レポート

糖尿病サプリメントの世界市場2021-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Diabetes Supplements Market (Type: Vitamins, Minerals, Proteins, Antioxidant & Fatty Acids, Dietary Fibers, and Others; Disease Type: Type 1 and Type 2; Dosage Form: Tablets, Solution, Powder, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが調査・発行した産業分析レポートです。糖尿病サプリメントの世界市場2021-2031:産業分析、規模、シェア、成長、動向、予測 / Diabetes Supplements Market (Type: Vitamins, Minerals, Proteins, Antioxidant & Fatty Acids, Dietary Fibers, and Others; Disease Type: Type 1 and Type 2; Dosage Form: Tablets, Solution, Powder, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2206A032資料のイメージです。• レポートコード:MRC2206A032
• 出版社/出版日:Transparency Market Research / 2022年4月
• レポート形態:英文、PDF、197ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートでは、世界の糖尿病サプリメント市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別(ビタミン、ミネラル、タンパク質、抗酸化物質&脂肪酸、食物繊維)分析、疾患タイプ別分析、剤形別分析、流通チャネル別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の内容をまとめております。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の糖尿病サプリメント市場規模:種類別(ビタミン、ミネラル、タンパク質、抗酸化物質&脂肪酸、食物繊維)
・世界の糖尿病サプリメント市場規模:疾患タイプ別
・世界の糖尿病サプリメント市場規模:剤形別
・世界の糖尿病サプリメント市場規模:流通チャネル別
・世界の糖尿病サプリメント市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Diabetes Supplements Market – Scope of Report

TMR’s report on the global diabetes supplements market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global diabetes supplements market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global diabetes supplements market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the diabetes supplements market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global diabetes supplements market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global diabetes supplements market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global diabetes supplements market.

The report delves into the competitive landscape of the global diabetes supplements market. Key players operating in the global diabetes supplements market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global diabetes supplements market profiled in this report.

Key Questions Answered in Diabetes Supplements Market Report
What will be the sales/revenue generated by diabetes supplements across all regions during the forecast period?
What are the opportunities in the global diabetes supplements market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Diabetes Supplements Market – Research Objectives and Research Approach
The comprehensive report on the global diabetes supplements market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global diabetes supplements market in terms of disease type, dosage form, distribution channel, type, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global diabetes supplements market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diabetes Supplements Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diabetes Supplements Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
5.2. Key Industry Events (products launch, approval, merger & acquisition, etc.)
5.3. Epidemiology of Diabetes, by Region/Country
6. Global Diabetes Supplements Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Vitamins
6.3.2. Minerals
6.3.3. Proteins
6.3.4. Antioxidant & Fatty Acids
6.3.5. Dietary Fibers
6.3.6. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Diabetes Supplements Market Analysis and Forecast, by Disease Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease Type, 2017–2031
7.3.1. Type 1
7.3.2. Type 2
7.4. Market Attractiveness Analysis, by Disease Type
8. Global Diabetes Supplements Market Analysis and Forecast, by Dosage Form
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Dosage Form, 2017–2031
8.3.1. Tablets
8.3.2. Solution
8.3.3. Powder
8.3.4. Others
8.4. Market Attractiveness Analysis, by Dosage Form
9. Global Diabetes Supplements Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Distribution Channel, 2017–2031
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Diabetes Supplements Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Diabetes Supplements Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Vitamins
11.2.2. Minerals
11.2.3. Proteins
11.2.4. Antioxidant & Fatty Acids
11.2.5. Dietary Fibers
11.2.6. Others
11.3. Market Value Forecast, by Disease Type, 2017–2031
11.3.1. Type 1
11.3.2. Type 2
11.4. Market Value Forecast, by Dosage Form, 2017–2031
11.4.1. Tablets
11.4.2. Solution
11.4.3. Powder
11.4.4. Others
11.5. Market Value Forecast, by Distribution Channel, 2017–2031
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Disease Type
11.7.3. By Dosage Form
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Diabetes Supplements Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Vitamins
12.2.2. Minerals
12.2.3. Proteins
12.2.4. Antioxidant & Fatty Acids
12.2.5. Dietary Fibers
12.2.6. Others
12.3. Market Value Forecast, by Disease Type, 2017–2031
12.3.1. Type 1
12.3.2. Type 2
12.4. Market Value Forecast, by Dosage Form, 2017–2031
12.4.1. Tablets
12.4.2. Solution
12.4.3. Powder
12.4.4. Others
12.5. Market Value Forecast, by Distribution Channel, 2017–2031
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Disease Type
12.7.3. By Dosage Form
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Diabetes Supplements Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Vitamins
13.2.2. Minerals
13.2.3. Proteins
13.2.4. Antioxidant & Fatty Acids
13.2.5. Dietary Fibers
13.2.6. Others
13.3. Market Value Forecast, by Disease Type, 2017–2031
13.3.1. Type 1
13.3.2. Type 2
13.4. Market Value Forecast, by Dosage Form, 2017–2031
13.4.1. Tablets
13.4.2. Solution
13.4.3. Powder
13.4.4. Others
13.5. Market Value Forecast, by Distribution Channel, 2017–2031
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Disease Type
13.7.3. By Dosage Form
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Diabetes Supplements Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Vitamins
14.2.2. Minerals
14.2.3. Proteins
14.2.4. Antioxidant & Fatty Acids
14.2.5. Dietary Fibers
14.2.6. Others
14.3. Market Value Forecast, by Disease Type, 2017–2031
14.3.1. Type 1
14.3.2. Type 2
14.4. Market Value Forecast, by Dosage Form, 2017–2031
14.4.1. Tablets
14.4.2. Solution
14.4.3. Powder
14.4.4. Others
14.5. Market Value Forecast, by Distribution Channel, 2017–2031
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Disease Type
14.7.3. By Dosage Form
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Diabetes Supplements Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2031
15.2.1. Vitamins
15.2.2. Minerals
15.2.3. Proteins
15.2.4. Antioxidant & Fatty Acids
15.2.5. Dietary Fibers
15.2.6. Others
15.3. Market Value Forecast, by Disease Type, 2017–2031
15.3.1. Type 1
15.3.2. Type 2
15.4. Market Value Forecast, by Dosage Form, 2017–2031
15.4.1. Tablets
15.4.2. Solution
15.4.3. Powder
15.4.4. Others
15.5. Market Value Forecast, by Distribution Channel, 2017–2031
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Disease Type
15.7.3. By Dosage Form
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by Tier and Size of companies)
16.2. Market Share Analysis/Ranking by Company (2020)
16.3. Company Profiles
16.3.1. Abbott (Abbott Healthcare Pvt. Ltd.)
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Aksuvital Natural Products Co.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. Arkopharma
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Bionova
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Caelus Health
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. CuraLife Commerce SIA
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Glucose Health, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Hexagon Nutrition Pvt. Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. La Grande P Ltd. (La Nutraceuticals)
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Company Financials
16.3.9.3. Growth Strategies
16.3.9.4. SWOT Analysis
16.3.10. Lysulin, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Company Financials
16.3.10.3. Growth Strategies
16.3.10.4. SWOT Analysis
16.3.11. Nature’s Sunshine Products, Inc.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Company Financials
16.3.11.3. Growth Strategies
16.3.11.4. SWOT Analysis
16.3.12. Nestlé Health Science
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Company Financials
16.3.12.3. Growth Strategies
16.3.12.4. SWOT Analysis
16.3.13. Nutricia
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Company Financials
16.3.13.3. Growth Strategies
16.3.13.4. SWOT Analysis
16.3.14. Olive Healthcare
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Company Financials
16.3.14.3. Growth Strategies
16.3.14.4. SWOT Analysis
16.3.15. Other Prominent Players
16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.15.2. Company Financials
16.3.15.3. Growth Strategies
16.3.15.4. SWOT Analysis

List of Tables

Table 01: Global Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 03: Global Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 04: Global Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 05: Global Diabetes Supplements Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America Diabetes Supplement Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 08: North America Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 09: North America Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 10: North America Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 11: Europe Diabetes Supplement Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 12: Europe Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 13: Europe Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 14: Europe Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 15: Europe Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 16: Asia Pacific Diabetes Supplement Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 17: Asia Pacific Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 18: Asia Pacific Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 19: Asia Pacific Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 20: Asia Pacific Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 21: Latin America Diabetes Supplement Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 22: Latin America Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Latin America Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 24: Latin America Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 25: Latin America Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 26: Middle East & Africa Diabetes Supplement Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 27: Middle East & Africa Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 28: Middle East & Africa Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 29: Middle East & Africa Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 30: Middle East & Africa Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031